ULTRASE MT18 18,000 UNT / 58,500 UNT / 58,500 UNT Delayed Release Oral Capsule
RxNorm 807734
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 807734 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ULTRASE MT18 18,000 UNT / 58,500 UNT / 58,500 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 58500 UNT / lipase 18000 UNT / protease 58500 UNT Delayed Release Oral Capsule [Ultrase]
(Atom ID: 12361229)
SY
Synonym (SY):
Ultrase (amylases 58,500 UNT / endopeptidases 58,500 UNT / lipase 18,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845959)
SY
Synonym (SY):
Ultrase MT 18 (amylase 58,500 UNT / lipase 18,000 UNT / protease 58,500 UNT) Delayed Release Oral Capsule
(Atom ID: 11845958)
SY
Synonym (SY):
Ultrase MT 18 Delayed Release Oral Capsule
(Atom ID: 6339207)
PSN